Kinentia Biosciences
Curated by SignalCompany that offers a chemoinformatics platform for drug discovery and development
Overview
Kinentia Biosciences has developed a chemoinformatics platform called Deep Data Mining (DDM) for recognizing the key risk factors involved in the drug discovery process and has also come up with process related checks to mitigate them. The company has 3 major divisions which offer consulting services, CRAMS services and a catalog of chemical intermediates, building blocks and natural products through its subsidiary KCS online. The company claims to have expertise in areas such as medicinal chemistry, process development, cGMP manufacturing, CMC, polymorphism and solid state chemistry services. The company's DDM platform can be used for generating novel chemical entities which have special affinity to a particular protein target and also offer ADMET predictor algorithms.
Key facts
- Founded
- 2007
- Headquarters
- Albany, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 6 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Sign up to view
- Phone
- Sign up to view